ERYTECH wins the European Small and Mid-Cap Award in the Most Innovative Newcomer category Post author:admERY Post published:December 10, 2015 Post category:Newsroom ERYTECH announced today that it received yesterday evening the “European Small and Mid-Cap” award in the “Most Innovative Newcomer” category by the Federation of European Stock Exchanges. You Might Also Like ERYTECH’S COMBINED SHAREHOLDERS’ MEETING May 26, 2020 ERYTECH Pharma announces the oral presentation of positive Phase II clinical trial results in Acute Lymphoblastic Leukemia. June 17, 2012 ERYTECH Announces Presentation of Results of Expanded Access Program in ALL at 2021 ASH Annual Meeting and Acceptance of Two Abstracts at ASCO GI December 13, 2021
ERYTECH Pharma announces the oral presentation of positive Phase II clinical trial results in Acute Lymphoblastic Leukemia. June 17, 2012
ERYTECH Announces Presentation of Results of Expanded Access Program in ALL at 2021 ASH Annual Meeting and Acceptance of Two Abstracts at ASCO GI December 13, 2021